Anti-EGFR therapy

The FDA ( Food and Drug Administration ) has approved a new second-generation lung cancer treatment that can help many...


The anti-EGFR monoclonal antibodies Panitumumab ( Vectibix ) and Cetuximab ( Erbitux ) are effective in patients with chemotherapy-refractory wild-type...


Bayer HealthCare has announced that the European Commission has approved Stivarga ( Regorafenib ) tablets for the treatment of adult...


A subset of colorectal cancers responds to anti-epidermal growth factor receptor ( anti-EGFR ) therapies, but develops resistance within months....


Results from a clinical trial conducted in Shanghai, China, have indicated that adding Cetuximab ( Erbitux ) to standard chemotherapy...


In patients with KRAS, wild-type metastatic colorectal cancer ( mCRC ) a head to head comparison of anti-EGFR- and anti-VEGF-directed...


Bayer HealthCare has announced that the Food and Drug Administration ( FDA ) approved Stivarga ( Regorafenib ) tablets for...


European Researchers have found that metastatic colorectal cancer patients with a mutation in the BRAF gene do not respond to...


The anti-epidermal growth factor receptor ( anti-EGFR ) Cetuximab ( Erbitux ) has been proven to be efficient in metastatic...